Authors: Tomomi Ichiba, Tetsuo Miyagawa, Takeshi Kera, Tohru Tsuda
Categories: Original Article, Chronic obstructive pulmonary disease, Manual chest wall compression technique, Respiratory motor output
Source: Journal of Physical Therapy Science
Doi: 10.1589/jpts.30.1349
obstructive pulmonary disease
[Purpose] Pulmonary rehabilitation is appropriate for most individuals with chronic
obstructive pulmonary disease (COPD). Pulmonary rehabilitation consists of conditioning
and exercise therapy. Conditioning includes relaxation, breathing exercises, and manual
chest wall compression during expiration (CWC). CWC improves the symptoms in individuals
with respiratory disease who have undergone mechanical ventilation. However, evidence
supporting the effectiveness of CWC for COPD has been insufficient. This study aimed to
determine physiological responses to CWC in participants with COPD. [Participants and
Methods] Twenty-nine participants with COPD were included in the study. Manual CWC
techniques were performed in a comfortable position chosen by the participants (sitting,
forward-leaning (sitting), or semi-Fowler’s). Ventilatory parameters, occlusion airway
pressure (P0.1), and dyspnea were assessed using a visual analog scale and were
compared before and during CWC. [Results] During manual CWC, oxygen consumption, carbon
dioxide production, end-tidal carbon dioxide concentration, and dyspnea were significantly
decreased; however, P0.1 was not affected. [Conclusion] Manual CWC for COPD had
an immediate physiological effect, including a decrease in dyspnea that may have been
facilitated by a reduced workload of the respiratory muscles. Thus, manual CWC may be
effective for dyspnea by reducing oxygen consumption in the respiratory muscles.
Keywords: Chronic obstructive pulmonary disease, Manual chest wall compression technique, Respiratory motor output
Pulmonary rehabilitation is appropriate for most individuals with chronic obstructive pulmonary disease (COPD). Pulmonary rehabilitation consists of conditioning and exercise therapy. Conditioning includes relaxation, breathing exercises, and manual chest wall compression during expiration (CWC). Exercise therapy primarily consists of exercise, including limb muscle strength training and endurance training via walking or ergometer^1^^, ^^2^^)^. Because dyspnea frequently observed in chronic respiratory disease is one of the limiting factors of exercise, the effect of exercise therapy can change significantly depending on success in controlling dyspnea. CWC, in positions such as semi-Fowler’s, forward-leaning sitting with pillow, or forward-leaning sitting with supporting elbow on knee, is often used to improve dyspnea before, during, and after exercise. Using the manual CWC technique, patients exhale their own breath to a lower than functional residual capacity facilitated by pressure from a therapist’s hand; their thorax subsequently expands by its own elastic recoil. This reduces workload on the inspiratory muscles and increases tidal volume (VT). It appears that these interventions reduce dyspnea due to improved breathing efficiency and a reduction in the consumption of oxygen in respiratory muscles. There have been reports of the effects of CWC in COPD and symptomatic controls^3^^)^. However, evidence supporting the effectiveness of this technique has been insufficient, despite the frequency of use of this maneuver in Japan. Accordingly, the aim of this study was to experimentally verify the effects of manual CWC from a physiological perspective.
A total of 29 ambulatory participants (25 males, 4 females) with COPD (Global Initiative for Chronic Obstructive Lung Disease [GOLD] stage 1 [n=3]; stage 2 [n=11]; stage 3 [n=8]; stage 4 [n=7]), who did not require home oxygen therapy, were recruited from the Kirigaoka Tsuda Hospital (Fukuoka, Japan). None of the participants had severe orthopedic, cardiovascular, or central nervous system disorder(s), and all had locomotor abilities with/without cane (Table 1). The advantages and disadvantages of participating in this study were explained to all participants before informed written consent was obtained from each. This study was approved by the Kyorin University institutional ethics committee (approval no. 24-22 in 2014).
Vital capacity (VC), FEV1, FEV % in 1 s (FEV1%), and FVC were
measured using spirometry (HI-801, CHEST MI, Inc., Tokyo, Japan). Maximum inspiratory mouth
pressure (PImax) was measured using a respiratory muscle strength device (0100, Micro
Medical, Rochester Kent, UK).
Occlusion airway pressure (P0.1) was evaluated as an alternative index for
respiratory motor output^4^^,^^5^^,^^6^^)^. An airway occlusion
system (model 9326, Hans Rudolph, Shawnee Mission, KS, USA) was used to measure
P0.1 during exercise (dead space 48.9 ml). A differential pressure transducer
(DP-10, Validyne, CA, USA) was used to measure airway pressure, and a metabolic gas analyzer
(AE-300S, Minato Medical Science, Osaka, Japan) was used to measure ventilatory parameters.
A hot-wire flow transducer was connected to the outlet of the airway occlusion system, and a
mask (MAS0215, Minato Medical Science, Osaka, Japan) was connected to the oral side port. To
measure airway pressure, a differential pressure transducer was connected to the airway
occlusion system via a tube (diameter 4 mm) (Fig.
1). The inlet of the airway occlusion system was occluded using a balloon with manual
manipulation at the end of expiration, and held until the beginning of inspiration. Oral
pressure was measured 100 ms after beginning expiration and defined as P0.1^7^^, ^^8^^)^.
P0.1 was measured randomly five times, and the mean value calculated from 4
stable measurements was recorded^8^^)^.
Electrocardiography (WEP-7202, Nihonkoden, Tokyo, Japan) was used to measure heart rate.
Analog signals from raw flow pressure and electrocardiography were downloaded into a
personal computer via an AD converter (PowerLab 16/30, ADInstruments, Sydney, Australia) at
a sampling frequency of 1,000 Hz. These signals were analyzed using commercially available
software (Chart 5.3, ADInstruments, Sydney, Australia) to calculate VT, minute ventilation
(V̇E), oxygen consumption (V̇O2), carbon dioxide production (V̇CO2),
end-tidal carbon dioxide concentration (ETCO2), breathing frequency, heart rate,
and P0.1. A 10 cm visual analog scale was used to measure dyspnea. Because COPD
is characterized by weakness in respiratory muscle strength, P0.1 was corrected
to PImax (P0.1/PImax)^9^^)^.
Fig. 1. Measuring equipment. The airway occlusion system used to measure P
0.1. A pressure transducer was connected to the side port of the airway occlusion system to measure mouth pressure, while a hot-wire flow transducer from the gas analyzer was connected to the expiratory port. The analog signal from the gas analyzer, as well as measurements from the pressure transducer, were continuously recorded using an analog-to-digital converter. PC: Personal computer.
Participants were first asked to place themselves in a sitting, forward-leaning (sitting), and semi-Fowler’s position, and asked to choose for themselves the most comfortable position for breathing. These positions are described as sitting position (sitting on a chair with a backrest, with feet touching the floor; forward-leaning sitting position (body bent forward with a pillow); semi-Fowler’s position (lying on a bed with head at a 30° and knees slightly bent). A senior physical therapist performed manual CWC by way of pressing on the bilateral lower rib cage during expiration. The strength of rib cage compression was adjusted to one in which the participants were most comfortable based on interview feedback.
Participants were asked to place themselves in their chosen position; ventilation and HR
were measured for 5 min thereafter. They then received manual CWC from a therapist while
remaining in the same position. Manual CWC was continued for 5 min, after which
P0.1 measurements were repeated five times at 1 min intervals. Finally, dyspnea
before/after manual CWC was assessed according to a visual analog scale.
SPSS version 21.0 (IBM Corporation, Armonk, NY, USA) was used for statistical analysis. The correlation between GOLD stage and respiratory function was determined using Pearson correlation analysis. The χ^2^ test was used to compare GOLD stage and positioning. The Paired t-test and Wilcoxon signed-rank tests were used to compare values before and after manual breathing assistance. All values are expressed as mean ± standard deviation, and statistical significance was set at p<0.05.
The positioning selected by the participants is summarized in Table 2. Chosen positioning differed according to individual GOLD the
semi-Fowler’s position was most frequently chosen by participants in GOLD stage 3; the
forward-leaning sitting position was chosen most by those in GOLD stage 4 (p=0.03). Among
all participants, 19 (65.5%) chose the semi-Fowler’s position. Changes in ventilation index
before and after breathing assistance are summarized in Tables 3 and 4. V̇O2, V̇CO2, ETCO2, and visual analog scale
decreased after manual breathing assistance (p=0.003, p=0.003, p<0.001, p<0.001,
respectively) although VT, P0.1, and P0.1/PImax were not affected.
In our study, the most comfortable breathing position chosen by participants with COPD differed according to their GOLD stage. The reason for reduced dyspnea based on positioning is explained by ventilatory mechanics. When supine, the abdominal viscus presses the diaphragm into the rib cage compared with the upright position^10^^)^. Therefore, although elevation of the diaphragm is supported by these pressures during expiration, stronger contractions are needed to move the diaphragm. The tension-length relationship of the diaphragm is improved by its movement into the rib cage in the supine position^11^^)^. These effects, however, are altered to the contrary in the upright position. The semi-Fowler’s position confers benefits from both the effect of gravity and improvement in length-tension relationship because it is intermediary between lying and upright. Furthermore, the semi-Fowler’s position is equivalent to the lying position given that the entire body is supported by an external surface. Oxygen consumption may be lower because of low skeletal muscle activity while in the semi-Fowler’s position.
Only participants in GOLD stage 4 chose the forward-leaning sitting position instead of the semi-Fowler’s position. The forward leaning posture has been shown to be highly effective and is probably the body position most adopted by patients with lung disease^12^^,^^13^^,^^14^^)^. The effectiveness of this position does not appear to be related to the severity of airway obstruction, changes in V̇E, or improved oxygenation. Hyperinflation and paradoxical abdominal movement were, in fact, reported to be related to the relief of dyspnea in the forward-leaning position. Alternatively, forward leaning has been associated with a significant reduction in electromyographic activity of the scalene and sternomastoid muscles under transdiaphragmatic pressure^12^^)^. From these studies, it was concluded that the subjective improvement of dyspnea in patients with COPD was the result of a more favorable position of the diaphragm with regard to its length-tension curve. In addition, forward leaning with arm support enables accessory muscles (pectoralis minor and major) to significantly contribute to rib cage elevation. The same holds true for the forward leaning position with head support, enabling the accessory neck muscles to assist inspiration. The forward-leaning sitting position facilitates increases in the diameter or circumference of the rib cage and lung volume; consequently, individuals in this position experience improved dyspnea^15^^,^^16^^,^^17^^)^. These facts may be the reason that forward-leaning sitting was chosen as most comfortable position in patients in GOLD stage 4. Postures in which participants were most comfortable differed according to disease severity. Therefore, we chose to perform our evaluations from among sitting, forward-leaning, and semi-Fowler’s positioning in our study.
Several studies have also reported that manual CWC during expiration increases expiratory
flow rates, improves removal of airway secretions, gas exchange, and pulmonary mechanics in
patients on mechanical ventilation^18^^,^^19^^,^^20^^)^,
and those with cystic fibrosis^21^^)^,
COPD^22^^)^, and asthma^23^^)^. The physiological effects of CWC have been studied in
patients with COPD^3^^)^. During CWC, the COPD
group demonstrated significantly higher peak expiratory and inspiratory flow rates, VT,
inspiratory capacity, inspiratory and expiratory times, and the ratio of VT to inspiratory
time, than during quiet breathing, but not V̇50 and V̇25^3^^)^. These results suggest that CWC may reduce
hyperinflation in COPD. In fact, CWC has been used as a technique to reduce dyspnea by
reducing hyperinflation^24^^)^.
V̇O2 and V̇CO2 were significantly decreased, in addition to dyspnea,
in our study. It appeared that decreases in V̇O2 and V̇CO2 reflected
decreasing respiratory muscle mechanical activity and respiratory muscle metabolism.
Respiratory muscle oxygen uptake and consumption were also possibly decreased by CWC.
Furthermore, substantial alveolar ventilation increased when considering decreasing
ETCO2, although it did not decrease and VT did not increase, despite our
predicted results. These results appear to reflect the physiological effect of manual CWC on
the respiratory muscles.
We used P0.1 as an alternative respiratory motor output measure because it has
been intimately connected with dyspnea, and could be evaluated objectively^7^^, ^^25^^)^.
In patients with COPD, P0.1 is clearly higher than in healthy participants^26^^, ^^27^^)^, and higher with increasing severity^28^^)^. However, both P0.1 and P0.1/PImax were not
different before/after manual CWC. Manual CWC is a maneuver in which lung volume is
decreased below functional residual capacity (FRC) by forced expirations. When the lung
volume is lowered by FRC at initial inspiration, P0.1 is strongly affected by
thoracic elastic recoil. Therefore, the resulting P0.1 value reflects inspiratory
effort added to thoracic elastic recoil. Although P0.1 was not decreased by
manual CWC in our study, we do not believe it increased respiratory motor output.
This study had limitations that should be addressed. Some short-term effects of manual CWC
were clearly visible from a physiological perspective; however, we could not examine whether
it had a measurable benefit for exercise (i.e., prolonged exercise endurance time, increased
V̇O2 max, or aerobic threshold). Furthermore, we considered decreased dyspnea
to be related to decreased respiratory muscle activity or respiratory motor output; however,
these differences were not reflected in the P0.1 values. This requires direct
evaluation of neuromuscular activity (e.g., using electromyography on respiratory muscle, or
performing near-infrared spectroscopy on the brain) to clarify supportive evidence. In
conclusion, the present study investigated the physiological effects of CWC in participants
with COPD. Manual CWC that was administered in positions most comfortable for the
participants improved oxygen consumption, respiratory rate, and dyspnea. We conclude that
manual CWC may lead to decreased dyspnea in individuals experiencing respiratory failure,
and that the physical responses were directly related to the technique.
This project, from which data were collected, was supported by Kyorin University.
The authors declare no conflict of interest associated with this manuscript.
The authors are grateful to the outpatients at Kirigaoka Tsuda hospital who participated in this study.